Filing Flows › Zimmer Biomet Holdings (ZBH) › Guidance & outlook
Zimmer Biomet Holdings (ZBH) guidance and outlook
Zimmer Biomet Holdings (ZBH) raised its guidance on Nov 4, 2026: EPS −$2.00 for FY2026.
Latest guidance
| Metric | Period | Range | Change |
|---|---|---|---|
| EPS | FY2026 | −$2.00 | reaffirmed |
From the earnings release filed Nov 4, 2026 (8-K on EDGAR).
Zimmer Biomet Holdings' latest quarter
Zimmer Biomet Holdings, Q3 2026: revenue $2.1B (+3% year over year), operating margin 14.9%, net earnings $193M, operating cash flow $560M. The chart follows the revenue to costs, profit and cash.
Questions
Did Zimmer Biomet Holdings raise or lower its guidance?
Zimmer Biomet Holdings (ZBH) raised its guidance on Nov 4, 2026: EPS −$2.00 for FY2026.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.